Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00514202
Status:
TERMINATED
Last Update Posted:
2012-02-22
First Post:
2007-08-07
Brief Title:
Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder ADHD
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Study Overview
Official Title:
Dextroamphetamine Treatment for Comorbid Cocaine Dependence and ADHD
Status:
TERMINATED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Investigator left UTHSC-Houston
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dextroamphetamine is commonly used to treat ADHD and recent evidence suggests that this medication may decrease drug use in individuals dependent on cocaine Thus the present pilot study will determine the ability of dextroamphetamine to treat individuals with both cocaine dependence and ADHD
Detailed Description:
This double-blind placebo-controlled pilot study will determine the ability of dextroamphetamine to treat comorbid cocaine dependence and ADHD Participants will be randomly assigned on receive placebo or Dextroamphetamine SR 60 mgday during a 12-week study period All participants will receive weekly cognitive behavioral therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P50DA009262 | NIH | None | httpsreporternihgovquickSearchP50DA009262 |